Ketamine approved as public treatment for acute suicidality in Norway

Ketamine has been approved as a public treatment for acute suicidality in Norway. The decision follows cases where traditional therapies failed to provide relief for severe mental health conditions.

Vilde Krum Dahl, a 34-year-old who has struggled with complex PTSD and clinical depression, describes the treatment as a life-saving intervention. After experiencing traumatic events and finding no success with antidepressants, talk therapy, exposure therapy, or cognitive therapy, she turned to ketamine to manage her condition.